Nan Mu
- Molecular Biology top 10%
- Cancer Research top 5%
- Physiology top 10%
- Oncology
- Epidemiology
- Topics
- Metabolism, Diabetes, and Cancer (6 papers)MicroRNA in disease regulation (5 papers)Endometrial and Cervical Cancer Treatments (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Nan Mu
55 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 774
- Cancer Research 320
- Physiology 216
- Oncology 183
- Epidemiology 174
Countries citing papers authored by Nan Mu
This map shows the geographic impact of Nan Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Mu more than expected).
Fields of papers citing papers by Nan Mu
This network shows the impact of papers produced by Nan Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Mu. The network helps show where Nan Mu may publish in the future.
Co-authorship network of co-authors of Nan Mu
This figure shows the co-authorship network connecting the top 25 collaborators of Nan Mu. A scholar is included among the top collaborators of Nan Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Mu. Nan Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 16 | |
| 3 | 1 | |
| 4 | 15 | |
| 5 | 14 | |
| 6 | 59 | |
| 7 | 70 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 10 | |
| 11 | 67 | |
| 12 | 58 | |
| 13 | 19 | |
| 14 | 9 | |
| 15 | 2 | |
| 16 | 127 | |
| 17 | 65 | |
| 18 | 34 | |
| 19 | 35 | |
| 20 | 30 |
About Nan Mu
Nan Mu is a scholar working on Geriatrics and Gerontology, Obstetrics and Gynecology and Cancer Research, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (6 papers), MicroRNA in disease regulation (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). The work is most often cited by research in Cancer Research (320 citations), Geriatrics and Gerontology (83 citations) and Biological Psychiatry (34 citations). Nan Mu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Heng Ma, Lu Yu, Yishi Wang, Yue Yin, Manling Liu, Yingmei Wang, Jintao Gu, Wangqian Zhang, Fengxia Xue and Xiaochang Xue. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.